Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NVUSPH · Entity 379 | Chief Operating Officer | August 31, 2021 | August 31, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
U S PHYSICAL THERAPY INC /NV
Report date August 31, 2021 · Filed August 31, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,867 |
Reported balance
After 2021-08-31 transaction · row 1
1 source rowRow 1 · 2021-08-31 · Sale · Disposed 6,202 · Balance 13,867 F1: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $116.40 to $117.85, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $116.40 to $117.85, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 31, 2021 Filed Aug 31, 2021 19:54 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 6,202 | $117.30 | $727,494.60 |
DisclosureSEC source: 0001209191-21-054050 · doc4.xml · nonDerivative · entry 1 McDowell Glenn · CIK 0001315304 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,867 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $116.40 to $117.85, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 17:10 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 5,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013672 · doc4.xml · nonDerivative · entry 1 McDowell Glenn · CIK 0001315304 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,069 F1 · shares: The 5,600 shares of common stock was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan of which 4,400 under the Companys Discretionary Long-Term Incentive Plan for Senior Management and 1,200 as an additional grant. Restrictions lapse in 16 equal quarterly installment with the first 350 shares on April 1, 2021 and thereafter with 350 shares on April 1, July 1, October 1 and January 1 of each year with the final 350 shares lapsing on January 1, 2025, if he is employed by the Company on those dates. F2 · balance_after: Inclusive of the above 5,600 shares in footnote 1, includes 17, 885 shares which restrictions lapse as to 2,009 shares on each of April 1, July 1 and October 1, 2021; 2,017 shares on January 1, 2022; 1,377 on each of April 1, July 1 and October 1, 2022; 1,380 shares on January 1, 2023; 729 shares on each of April 1, July 1 and October 1, 2023; 743 shares on January 1, 2024; and 350 shares on each of April 1, July 1 and October 1, 2023 and 350 shares on January 1, 2025, if he is employed by the Company on those dates. Read SEC document |
| November 10, 2020 Filed Nov 13, 2020 15:10 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 11,507 | $106.12 | $1,221,122.84 |
DisclosureSEC source: 0001209191-20-058215 · doc4.xml · nonDerivative · entry 1 McDowell Glenn · CIK 0001315304 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,469 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $105.80 to $106.63, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 14,469 shares which restrictions lapse as to 2,184 shares on January 1, 2021; 1,659 shares on each of April 1, July 1 and October 1, 2021; 1,667 shares on January 1, 2022; 1,027 shares on each of April 1, July 1 and October 1, 2022; 1,030 shares on January 1, 2023; 379 shares on each of April 1, July 1 and October 1 2023 and 393 shares on January 1, 2024, if he is employed by the Company on those dates. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 19:20 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 6,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-016491 · doc4.xml · nonDerivative · entry 1 McDowell Glenn · CIK 0001315304 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,976 F1 · shares: The 6,078 shares of common stock was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 16 equal quarterly installment with the 379 shares on April 1, 2020 and thereafter with 379 shares on April 1, July 1, October 1 and January 1 of each year with the final 393 shares lapsing on January 1, 2024, if he is employed by the Company on those dates. F2 · balance_after: Includes 20,976 shares which restrictions lapse as to 2,169 shares on each of April 1, July 1 and October 1, 2020; 2,184 shares on January 1, 2021; 1,659 shares on each of April 1, July 1 and October 1, 2021; 1,667 shares on January 1, 2022; 1,027 shares on each of April 1, July 1 and October 1, 2022; 1,030 shares on January 1, 2023; 379 shares on each of April 1, July 1 and October 1 2023 and 393 shares on January 1, 2024, if he is employed by the Company on those dates. Read SEC document |
| August 14, 2019 Filed Aug 15, 2019 16:57 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 5,000 | $134.55 | $672,750.00 |
DisclosureSEC source: 0001209191-19-046056 · doc4.xml · nonDerivative · entry 1 McDowell Glenn · CIK 0001315304 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,898 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $134.50 to $134.86 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 19,898 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 2,500 shares on each of October 1, 2019 and January 1, 2020; 1,790 shares on each of April 1, July 1 and October 1, 2020; 1,805 shares on January 1, 2021; 1,280 shares on each of April 1, July 1 and October 1, 2021; 1,288 on January 1, 2022; 648 on each of April 1, July 1 and October 1, 2022; and 651 on January 1, 2023. Read SEC document |
| March 18, 2019 Filed Mar 18, 2019 20:16 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 5,399 | $106.63 | $575,695.37 |
DisclosureSEC source: 0001209191-19-019985 · doc4.xml · nonDerivative · entry 3 McDowell Glenn · CIK 0001315304 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,898 F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $106.00 to $107.37 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 24,898 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 2,500 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; 1,790 shares on each of April 1, July 1 and October 1, 2020; 1,805 shares on January 1, 2021; 1,280 shares on each of April 1, July 1 and October 1, 2021 and 1,288 shares on January 1, 2022; 648 on each of April 1, July 1 and October 1, 2022; and 651 on January 1, 2023. Read SEC document |
| March 15, 2019 Filed Mar 18, 2019 20:16 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 405 | $110.10 | $44,590.50 |
DisclosureSEC source: 0001209191-19-019985 · doc4.xml · nonDerivative · entry 2 McDowell Glenn · CIK 0001315304 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,297 F2 · balance_after: Includes 24,898 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 2,500 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; 1,790 shares on each of April 1, July 1 and October 1, 2020; 1,805 shares on January 1, 2021; 1,280 shares on each of April 1, July 1 and October 1, 2021 and 1,288 shares on January 1, 2022; 648 on each of April 1, July 1 and October 1, 2022; and 651 on January 1, 2023. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 20:16 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 400 | $112.48 | $44,992.00 |
DisclosureSEC source: 0001209191-19-019985 · doc4.xml · nonDerivative · entry 1 McDowell Glenn · CIK 0001315304 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,702 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $112.44 to $112.49 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 24,898 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 2,500 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; 1,790 shares on each of April 1, July 1 and October 1, 2020; 1,805 shares on January 1, 2021; 1,280 shares on each of April 1, July 1 and October 1, 2021 and 1,288 shares on January 1, 2022; 648 on each of April 1, July 1 and October 1, 2022; and 651 on January 1, 2023. Read SEC document |
| March 04, 2019 Filed Mar 5, 2019 22:10 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 10,371 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016713 · doc4.xml · nonDerivative · entry 1 McDowell Glenn · CIK 0001315304 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,102 F1 · shares: The 10,371 shares of common stock was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 16 equal quarterly installment with the 648 shares on April 1, 2019 and thereafter with 648 shares on April 1, July 1, October 1 and January 1 of each year with the final 651 shares lapsing on January 1, 2023. F2 · balance_after: Includes 24,898 shares, inclusive of the 10,371 shares in footnote 1, of restricted stock granted under the Company's equity plans. Restrictions lapse as to 2,500 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; 1,790 shares on each of April 1, July 1 and October 1, 2020; 1,805 shares on January 1, 2021; 1,280 shares on each of April 1, July 1 and October 1, 2021; 1288 shares on January 1, 2022; 648 on each of April 1, July 1 and October 1, 2022; and 651 on January 1, 2023. Read SEC document |
| August 03, 2018 Filed Aug 6, 2018 20:26 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 6,204 | $114.81 | $712,281.24 |
DisclosureSEC source: 0001209191-18-045527 · doc4.xml · nonDerivative · entry 1 McDowell Glenn · CIK 0001315304 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,731 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $114.10 - $116.90, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 20.731 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 3,102 shares on each of October 1, 2018 and January 1, 2019; 1,852 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 1,142 shares on each of April 1, July 1 and October 1, 2020; 1,157 shares on January 1, 2021; 632 shares on each of April 1, July 1 and October 1, 2021; and 640 shares on January 1, 2022. Read SEC document |
| March 15, 2018 Filed Mar 15, 2018 21:27 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon stock | 2,900 | $82.55 | $239,395.00 |
DisclosureSEC source: 0001209191-18-019908 · doc4.xml · nonDerivative · entry 1 McDowell Glenn · CIK 0001315304 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,935 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.10 - $82.90, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 26,935 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 3,102 shares on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,852 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 1,142 shares on each of April 1, July 1 and October 1, 2020; 1,157 shares on January 1, 2021; 632 shares on each of April 1, July 1 and October 1, 2021; and 640 shares on January 1, 2022. Read SEC document |
| March 14, 2018 Filed Mar 15, 2018 14:59 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,179 | $83.27 | $98,175.33 |
DisclosureSEC source: 0001209191-18-019764 · doc4.xml · nonDerivative · entry 1 McDowell Glenn · CIK 0001315304 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,835 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $83.20 - $83.40, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 26,935 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 3,102 shares on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,852 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 1,142 shares on each of April 1, July 1 and October 1, 2020; 1,157 shares on January 1, 2021; 632 shares on each of April 1, July 1 and October 1, 2021; and 640 shares on January 1, 2022. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 19:56 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 205 | $85.45 | $17,517.25 |
DisclosureSEC source: 0001209191-18-019523 · doc4.xml · nonDerivative · entry 2 McDowell Glenn · CIK 0001315304 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,014 F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.45 - $85.55, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 26,935 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 3,102 shares on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,852 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 1,142 shares on each of April 1, July 1 and October 1, 2020; 1,157 shares on January 1, 2021; 632 shares on each of April 1, July 1 and October 1, 2021; and 640 shares on January 1, 2022. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 19:56 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 2,538 | $86.16 | $218,674.08 |
DisclosureSEC source: 0001209191-18-019523 · doc4.xml · nonDerivative · entry 1 McDowell Glenn · CIK 0001315304 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,219 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.15 - $86.25, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 26,935 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 3,102 shares on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,852 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 1,142 shares on each of April 1, July 1 and October 1, 2020; 1,157 shares on January 1, 2021; 632 shares on each of April 1, July 1 and October 1, 2021; and 640 shares on January 1, 2022. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 19:44 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 10,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017652 · doc4.xml · nonDerivative · entry 1 McDowell Glenn · CIK 0001315304 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,757 F1 · shares: The 10,120 shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 16 quarterly installment with the first 15 installments of 632 shares each beginning on April 1, 2018 and thereafter with 632 shares on April 1, July 1, October 1 and January 1 of each year with the final 640 shares lapsing on January 1, 2022. F2 · balance_after: Includes the above mentioned shares and 16,185 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 2,470 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,220 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 510 on each of April 1, July 1 and October 1, 2020; and 525 on January 1, 2021. Read SEC document |
| August 30, 2017 Filed Sep 1, 2017 20:18 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,594 | $57.00 | $90,858.00 |
DisclosureSEC source: 0001209191-17-051055 · doc4.xml · nonDerivative · entry 2 McDowell Glenn · CIK 0001315304 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,236 F2 · balance_after: Includes the 23,637 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 3,407 on October 1, 2017; 3,415 on January 1, 2018; 2,470 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,220 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 510 on each of April 1, July 1 and October 1, 2020; and 525 on January 1, 2021. Read SEC document |
| August 29, 2017 Filed Sep 1, 2017 20:18 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,004 | $57.01 | $57,238.04 |
DisclosureSEC source: 0001209191-17-051055 · doc4.xml · nonDerivative · entry 1 McDowell Glenn · CIK 0001315304 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,830 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.00- $57.05, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes the 23,637 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 3,407 on October 1, 2017; 3,415 on January 1, 2018; 2,470 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,220 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 510 on each of April 1, July 1 and October 1, 2020; and 525 on January 1, 2021. Read SEC document |
| August 24, 2017 Filed Sep 6, 2017 20:01 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 6,599 | $58.17 | $383,863.83 |
DisclosureSEC source: 0001209191-17-051587 · doc4.xml · nonDerivative · entry 1 McDowell Glenn · CIK 0001315304 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,235 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.00 - $59.02, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes the 23,637 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 3,407 on October 1, 2017; 3,415 on January 1, 2018; 2,470 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,220 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 510 on each of April 1, July 1 and October 1, 2020; and 525 on January 1, 2021. Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 17:47 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 600 | $59.72 | $35,832.00 |
DisclosureSEC source: 0001209191-17-049905 · doc4.xml · nonDerivative · entry 2 McDowell Glenn · CIK 0001315304 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,834 F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $59.70- $59.80, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes the 23,637 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 3,407 on October 1, 2017; 3,415 on January 1, 2018; 2,470 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,220 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 510 on each of April 1, July 1 and October 1, 2020; and 525 on January 1, 2021. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 17:47 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,064 | $60.01 | $63,850.64 |
DisclosureSEC source: 0001209191-17-049905 · doc4.xml · nonDerivative · entry 1 McDowell Glenn · CIK 0001315304 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,434 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00- $60.05, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes the 23,637 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 3,407 on October 1, 2017; 3,415 on January 1, 2018; 2,470 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,220 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 510 on each of April 1, July 1 and October 1, 2020; and 525 on January 1, 2021. Read SEC document |
| March 24, 2017 Filed Mar 28, 2017 15:06 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 8,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-023050 · doc4.xml · nonDerivative · entry 1 McDowell Glenn · CIK 0001315304 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,498 F1 · shares: The 8,175 shares of common stock was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 16 quarterly installment with the first 15 installments of 510 shares each beginning on April 1, 2017 and thereafter with 510 on April 1, July 1, October 1 and January 1 of each year with the final 525 shares lapsing on January 1, 2021. F2 · balance_after: Includes the 8,175 shares recently granted and 22,276 of restricted stock granted under the Company's equity plans. Restrictions lapse as to 3,407 on each of April 1, 2017, July 1, 2017, and October 1, 2017; 3,415 on January 1, 2018; 2,470 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,220 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 510 on each of April 1, July 1 and October 1, 2020; and 525 on January 1, 2021. Read SEC document |
| November 15, 2016 Filed Nov 16, 2016 17:28 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 4,047 | $61.15 | $247,474.05 |
DisclosureSEC source: 0001209191-16-150412 · doc4.xml · nonDerivative · entry 1 McDowell Glenn · CIK 0001315304 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,323 F1 · balance_after: Includes 26,323 of restricted stock granted under the Company's equity plans. Restrictions lapse as to 4,047 shares on January 1, 2017; 2,897 on each of April 1, 2017, July 1, 2017, and October 1, 2017; 2,905 on January 1, 2018; 1,960 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; and 710 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.